Skip to main content
Ion Beam Applications, SA logo

Ion Beam Applications, SA — Investor Relations & Filings

Ticker · IBAB ISIN · BE0003766806 LEI · 5493002RVRZ1S3CPUI26 BR Manufacturing
Open in API
Filings indexed 1,069 across all filing types
Latest filing 2025-04-02 Regulatory Filings
Country BE Belgium
Listing BR IBAB

About Ion Beam Applications, SA

https://www.iba-worldwide.com/

Ion Beam Applications (IBA) is a global company specializing in particle accelerator technology. It designs, manufactures, and markets advanced solutions for medical and industrial applications. The company is a leading supplier of proton therapy systems for the treatment of cancer. Its portfolio also includes dosimetry and quality assurance solutions for radiation therapy and medical imaging, as well as integrated systems for the production of radiopharmaceuticals (RadioPharma Solutions). Additionally, IBA provides industrial solutions, utilizing electron beam and X-ray accelerators for applications such as medical device sterilization and polymer modification.

Recent filings

Filing Released Lang Actions
250402_IBA-ProteusONE_Tri Service_FR.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by IBA (Ion Beam Applications S.A.) announcing the signing of a new contract for the installation of a Proteus®ONE proton therapy system at the Tri-Service General Hospital in Taiwan. It details the nature of the contract, quotes from the CEO and hospital director, and provides background information on both entities. Since this is a general corporate announcement regarding business operations and contract wins that does not fit into specific categories like M&A, earnings, or share issues, it is classified as a Regulatory Filing (RNS) which serves as the fallback for general corporate announcements.
2025-04-02 French
PR week 01 - Buyback - IBA - March 2025 (EN).pdf
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from Ion Beam Applications SA (IBA) detailing the specific transactions of a share buyback program. It provides a table of trade dates, number of shares purchased, and price data, which is characteristic of a 'Transaction in Own Shares' filing. It is not a report publication announcement, but rather the disclosure of the trading activity itself.
2025-03-31 English
PR week 01 - Buyback - IBA - March 2025 (FR).pdf
Transaction in Own Shares Classification · 1% confidence The document is a press release from Ion Beam Applications SA (IBA) detailing the company's share repurchase program. It provides specific data on the number of shares bought back, the dates of the transactions, and the average prices, as well as the updated total of treasury shares held. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2025-03-31 French
250324-IBA-share buy-back.pdf
Transaction in Own Shares Classification · 1% confidence The document explicitly announces the launch of a 'share buyback program' effective March 25th, 2025, detailing the maximum number of shares (650,000) to be repurchased and the objective (covering obligations from incentive plans). This action falls directly under the definition of a company buying back or selling its own shares. The filing type code corresponding to this activity is 'POS' (Transaction in Own Shares). The document is a press release announcing the action, not a regulatory form like a 10-K or an ER, but the core subject matter dictates the classification based on the provided definitions.
2025-03-24 English
250324-IBA-rachat-actions-propres.pdf
Transaction in Own Shares Classification · 1% confidence The document is a press release dated March 24, 2025, titled "IBA – Rachat d'actions propres" (IBA – Share Buyback). It explicitly announces the launch of a share repurchase program, detailing the maximum number of shares (650,000), the execution period (March 25, 2025, to December 31, 2025), and the legal basis (Code belge des sociétés et des associations). This content directly relates to the company buying back or selling its own shares. This matches the definition for Transaction in Own Shares (POS). The document length is short (2385 chars), but it is the primary announcement itself, not an announcement *about* the publication of a report, thus POS is more specific than RPA or RNS.
2025-03-24 French
250320-PR-IBA-FY-2024-Results-EN.pdf
Earnings Release Classification · 1% confidence The document is a comprehensive press release titled 'IBA reports solid Full Year 2024 results', dated March 20, 2025. It provides detailed financial highlights, segment-by-segment business reviews (Proton Therapy, Dosimetry, Other Accelerators), balance sheet information, and future guidance. While it contains financial tables and management commentary, it is structured as an initial announcement of the annual financial results rather than the full, audited Annual Report (10-K) document itself. Given its length and content, it fits the definition of an Earnings Release (ER). FY 2024
2025-03-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.